Conquering the hypoxia limitation for photodynamic therapy

Y Wan, LH Fu, C Li, J Lin, P Huang - Advanced Materials, 2021 - Wiley Online Library
Photodynamic therapy (PDT) has aroused great research interest in recent years owing to its
high spatiotemporal selectivity, minimal invasiveness, and low systemic toxicity. However …

The role of hypoxia‐inducible factor 1 in tumor immune evasion

L You, W Wu, X Wang, L Fang, V Adam… - Medicinal research …, 2021 - Wiley Online Library
Abstract Hypoxia‐inducible factor 1 (HIF‐1) plays an indispensable role in the hypoxic tumor
microenvironment. Hypoxia and HIF‐1 are involved in multiple aspects of tumor progression …

Perfluorocarbon@ Porphyrin nanoparticles for tumor hypoxia relief to enhance photodynamic therapy against liver metastasis of colon cancer

X Liang, M Chen, P Bhattarai, S Hameed, Z Dai - ACS nano, 2020 - ACS Publications
Photodynamic therapy (PDT) shows great promise for the treatment of colon cancer.
However, practically, it is a great challenge to use a nanocarrier for the codelivery of both the …

HIF inhibitors: status of current clinical development

J Fallah, BI Rini - Current oncology reports, 2019 - Springer
Abstract Purpose of Review In this review, the importance of the hypoxia inducible factor
(HIF) pathway in tumorigenesis and cancer treatment outcomes will be discussed. The …

Role of HIF-1 in cancer progression: novel insights. A review

A Pezzuto, E Carico - Current molecular medicine, 2018 - ingentaconnect.com
Hypoxia is a condition always present in tumor environment owing to the fast growth of
tumor cells not supported by adequate blood supply. There is increasing evidence that …

Metabolic hallmarks of tumor and immune cells in the tumor microenvironment

K Renner, K Singer, GE Koehl, EK Geissler… - Frontiers in …, 2017 - frontiersin.org
Cytotoxic T lymphocytes and NK cells play an important role in eliminating malignant tumor
cells and the number and activity of tumor-infiltrating T cells represent a good marker for …

Big opportunities for small molecules in immuno-oncology

JL Adams, J Smothers, R Srinivasan… - Nature reviews Drug …, 2015 - nature.com
The regulatory approval of ipilimumab (Yervoy) in 2011 ushered in a new era of cancer
immunotherapies with durable clinical effects. Most of these breakthrough medicines are …

Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention

D Colussi, G Brandi, F Bazzoli… - International journal of …, 2013 - mdpi.com
Research conducted during the past 30 years has increased our understanding of the
mechanisms involved in colorectal cancer initiation and development. The findings have …

Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2

NR Prabhakar, GL Semenza - Physiological reviews, 2012 - journals.physiology.org
Hypoxia is a fundamental stimulus that impacts cells, tissues, organs, and physiological
systems. The discovery of hypoxia-inducible factor-1 (HIF-1) and subsequent identification of …

The COX-2/PGE 2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

A Greenhough, HJM Smartt, AE Moore… - …, 2009 - academic.oup.com
It is widely accepted that alterations to cyclooxygenase-2 (COX-2) expression and the
abundance of its enzymatic product prostaglandin E 2 (PGE 2) have key roles in influencing …